These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3892359)

  • 1. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
    Zuzel KA; Rose C; Schwartz JC
    Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
    Rose C; Camus A; Schwartz JC
    Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8).
    Matsas R; Turner AJ; Kenny AJ
    FEBS Lett; 1984 Sep; 175(1):124-8. PubMed ID: 6090206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
    Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
    Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
    Camus A; Rose C; Schwartz JC
    Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
    Deschodt-Lanckman M; Strosberg AD
    FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the metabolism of CCK8 analogues by rat brain slices.
    Durieux C; Charpentier B; Pelaprat D; Roques BP
    Neuropeptides; 1986 Jan; 7(1):1-9. PubMed ID: 3456492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
    Najdovski T; Collette N; Deschodt-Lanckman M
    Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
    Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
    Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
    Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
    Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
    Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
    Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
    Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
    Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
    Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
    Giros B; Llorens-Cortes C; Gros C; Schwartz JC
    Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
    Waksman G; Hamel E; Fournié-Zaluski MC; Roques BP
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1523-7. PubMed ID: 3006054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody.
    Pollard H; De la Baume S; Bouthenet ML; Schwartz JC; Ronco P; Verroust P
    Eur J Pharmacol; 1987 Jan; 133(2):155-64. PubMed ID: 3545855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidase.
    Steardo L; Knight M; Tamminga CA; Barone P; Kask AM; Chase TN
    J Neurochem; 1985 Sep; 45(3):784-90. PubMed ID: 3897456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.